CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Predictive role of CD3, CD4, CD8, CD20 to neoadjuvant chemotherapy response in triple negative breast cancer patients

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 110
Year: 2015
COI code: ICBCMED12_150
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Predictive role of CD3, CD4, CD8, CD20 to neoadjuvant chemotherapy response in triple negative breast cancer patients

  Nafiseh Ansarinejad - Department of Hematology-Oncology, Iran University of Medical Sciences, Tehran, Iran.
  Farshid Fardad - Department of Hematology-Oncology, Iran University of Medical Sciences, Tehran, Iran.
  Bahareh Abbasi - Department of Medical Genetic, Medical Biotechnology Ins., National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
  Tayeb Ramim - Cancer Pharmacogenetics Research Group (CPGRG), Iran University of Medical Sciences, Tehran, Iran

Abstract:

Introduction & Aim: Tumor-infiltrating lymphocytes in breast cancer have been proposed as a new marker in the diagnosis of the patient s immune response. This study was aimed to determine predictive in response to neoadjuvant chemotherapy in patients with triple negative breast cancer. Methods: A cross-sectional study was done in 40 patients with breast cancer was referred to Cancer Institute, Imam Khomeini Hospital, Tehran, in April,2014 to April, 2016.T lymphocyte subtypes included CD3, CD4, CD8, CD20 and androgen receptor were investigated by Immunohistochemistry analysis pre and post-surgery. Pathologic complete response after surgery was determine Results: 22 patients were in Stage II and 18 patients were in Stage III. 13 patients had low levels of TILs and 27 patients had high levels of TILs. Six patients were positive in androgen receptor (AR).15 cases had a complete pathologic response. In the CD8-negative group, the most patients with low-levels of TILs had no complete pathological response but the most patients with high-levels of TILs had complete pathological response. In patients with CD20 positive had no impact on the patient s pathological response in terms ofthe TILs level, although, in the Absence and Mild level, the most pathological responses (80%) were negative and in the Moderate level, all pathological responses were positive. Conclusion: The findings of the study showed that Tumor-infiltrating lymphocytes can predict response to chemotherapy in patients with triple negative breast cancer after neoadjuvant therapy. Also, age, CD4 and CD8 indicators had predictive value to complete pathologic response based on TILs levels

Keywords:

Breast cancer, triple negative, lymphocytic infiltration, complete pathologic response

Perma Link

https://www.civilica.com/Paper-ICBCMED12-ICBCMED12_150.html
COI code: ICBCMED12_150

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Ansarinejad, Nafiseh; Farshid Fardad; Bahareh Abbasi & Tayeb Ramim, 2015, Predictive role of CD3, CD4, CD8, CD20 to neoadjuvant chemotherapy response in triple negative breast cancer patients, 12th International Congress on Breast Cancer, تهران, دانشگاه علوم پزشكي شهيد بهشتي, https://www.civilica.com/Paper-ICBCMED12-ICBCMED12_150.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Ansarinejad, Nafiseh; Farshid Fardad; Bahareh Abbasi & Tayeb Ramim, 2015)
Second and more: (Ansarinejad; Fardad; Abbasi & Ramim, 2015)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 3020
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.